Content area
Full text
[Image omitted] - 2014 change YTD: -66%
Market cap: $322M
Major holders at Sept. 30: North Tide Capital (9.65%), First Manhattan (8.9%), Vanguard Group (5.22%), State Street (5.09%), Tahithromos (4.75%), BlackRock (4.66%), Credit Suisse (4.3%), Meditor Group (2.86%) and Sarissa Capital (2.48%)
Why is it down? Vivus ($VVUS) has been on a long slide down since the spring of 2012 as investors have questioned its ability to bring in substantial revenue with its obesity drug Qsymia . The company only had $32.6 million in net product revenue during the first 9 months of 2014....